市场调查报告书
商品编码
1499605
关节重建市场:按固定类型、关节类型、材料、技术和最终用户划分 - 2024-2030 年全球预测Joint Replacement Market by Fixation Type (Cemented, Cementless, Hybrid), Joint Type (Ankle Replacement, Finger or Hand Joints Replacement, Hip Replacement), Material, Procedure, End-Use - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年关节重建市场规模为182.5亿美元,预计2024年将达192.2亿美元,2030年将达264.7亿美元,复合年增长率为5.45%。
关节重建手术是用人工关节取代受损或功能障碍的关节的外科手术。关节重建手术有助于缓解严重关节疼痛或退化性关节疾病患者的疼痛、改善活动能力并改善生活品质。关节重建手术的主要应用是在医疗领域,特别是用于治疗因各种疾病而遭受严重关节疼痛和丧失活动能力的患者。骨关节炎和类风湿性关节炎的盛行率不断增加,特别是在老年人中,增加了对关节重建手术的需求,也是市场成长的基础。人们对关节重建手术的认识不断提高以及与手术相关的报销政策的可用性进一步推动了市场的成长。替代治疗选择以及术后併发症和风险正在阻碍市场成长。手术技术方面不断涌现的技术创新和义肢设计的增强以改善手术效果预计将为市场成长创造机会。此外,使用具有优异耐用性和与人体相容性的材料也有望促进市场成长。
主要市场统计 | |
---|---|
基准年[2023] | 182.5亿美元 |
预测年份 [2024] | 192.2亿美元 |
预测年份 [2030] | 264.7亿美元 |
复合年增长率(%) | 5.45% |
区域洞察
美洲是一个不断增长的髋关节和膝关节关节重建市场,主要是由于需要控制导致关节退化的疾病(例如置换术和肥胖症)的流行,这是一个非常发达的地区。先进的医疗置换术和高昂的医疗成本也支撑了美洲髋关节和膝关节关节重建的庞大市场。在亚太地区,由于老年人口的增加、医疗水准的提高以及经济状况的改善,关节重建市场正在快速成长。中国、印度和日本等国家正受益于医疗设施的改善、愿意投资健康解决方案的中阶的崛起以及关节重建手术的普及。欧洲是关节重建手术的新兴市场,拥有先进的医疗保健系统和较高的关节重建手术认知度。支持性健康保险和报销政策也促进了欧洲、中东和非洲市场的成长。由于医疗基础设施的改善和政府对医疗服务的倡议,中东和非洲的关节重建市场正在成长。
FPNV定位矩阵
FPNV 定位矩阵对于评估供应商在关节重建市场的定位至关重要。此矩阵提供了对供应商的全面评估,并检验了与业务策略和产品满意度相关的关键指标。这种详细的评估使用户能够根据自己的要求做出明智的决定。根据评估结果,供应商被分为代表其成功程度的四个像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对关节重建市场中供应商的现状进行深入而详细的评估。透过仔细比较和分析供应商的贡献,您可以更深入地了解每个供应商的绩效以及他们在争夺市场占有率时面临的挑战。这些贡献包括整体收益、客户群和其他关键指标。此外,该分析还提供了对该行业竞争性质的宝贵见解,包括在研究基准年期间观察到的累积、分散主导地位和合併特征等因素。有了这些详细信息,供应商可以做出更明智的决策并製定有效的策略,以在市场竞争中保持领先地位。
策略分析与建议
策略分析对于寻求在全球市场站稳脚跟的组织至关重要。对目前关节重建市场地位的全面评估使公司能够做出符合其长期愿望的明智决策。此关键评估涉及对组织的资源、能力和整体绩效进行彻底分析,以确定核心优势和需要改进的领域。
[185 Pages Report] The Joint Replacement Market size was estimated at USD 18.25 billion in 2023 and expected to reach USD 19.22 billion in 2024, at a CAGR 5.45% to reach USD 26.47 billion by 2030.
Joint replacement is a surgical procedure in which damaged or dysfunctional joints are replaced with prosthetics. Joint replacement helps to relieve pain, improve mobility, and enhance the quality of life for individuals suffering from severe joint pain or degenerative joint diseases. The primary application of joint replacements is in the medical field, particularly in treating patients suffering from severe joint pain and immobility due to various conditions. The increased prevalence of osteoarthritis and rheumatoid arthritis, especially among the elderly population, is raising the need for joint replacement surgeries, creating a platform for market growth. Growing awareness about joint replacement surgeries and the availability of reimbursement policies associated with surgeries are further driving the market's growth. The availability of alternative treatment options and certain post-surgery complications and risks hamper the market growth. Rising innovations in surgical techniques and enhancements in prosthetic design that improve the outcomes of joint replacement surgeries are expected to create opportunities for market growth. Using materials that offer greater durability and compatibility with the human body is also expected to contribute to the market's growth.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 18.25 billion |
Estimated Year [2024] | USD 19.22 billion |
Forecast Year [2030] | USD 26.47 billion |
CAGR (%) | 5.45% |
Regional Insights
Americas represents a highly developing landscape for joint replacement surgeries, primarily due to an increasing need to manage the rising prevalence of conditions including osteoarthritis and obesity that contribute to joint degeneration. Advanced healthcare infrastructure and higher healthcare expenditure also support a large market for both hip and knee replacement surgeries in the Americas. The APAC region is experiencing rapid growth in the joint replacement market due to an increasing elderly population, rising healthcare standards, and improving economic conditions contribute to this growth. Countries including China, India, and Japan have benefitted from the growing accessibility to healthcare facilities and a rising middle class willing to invest in health solutions, subsequently expanding the accessibility of joint replacement surgeries. Europe is a developing market for joint replacement with advanced healthcare systems and high awareness of joint replacement procedures. Supportive health insurance and reimbursement policies also contribute to the market growth in EMEA. The Middle East and Africa have a growing joint replacement market, influenced by improving healthcare infrastructure and government initiatives towards health services.
Market Insights
The market dynamics represent an ever-changing landscape of the Joint Replacement Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.
FPNV Positioning Matrix
The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Joint Replacement Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Joint Replacement Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Recent Developments
Intellijoint Surgical Expands Market Reach with Intellijoint KNEE Approval in Japan
Intellijoint Surgical received regulatory approval in Japan for its innovative product, Intellijoint KNEE, marking a significant expansion in the global computer-assisted surgical navigation market. This technology offers orthopedic surgeons real-time, accurate measurements for surgical cutting guides during total knee replacements. It is adaptable to all implant brands, enhancing its integration into existing surgical workflows. [Published On: 2024-03-07]
FDA Approval Enhances Treatment for Early-Stage Knee Osteoarthritis
The U.S. Food and Drug Administration (FDA) approved the MISHA Knee System, an implantable device designed to alleviate symptoms of early-stage knee osteoarthritis. Specifically targeting patients experiencing persistent pain despite conventional nonsurgical interventions, such as weight loss and physical therapy, this device strategically reduces the weight-bearing load by one-third on the medial side of the knee, thereby lessening joint stress. Primarily aimed at patients not yet requiring total knee replacement, the MISHA Knee System is a transitional solution, potentially delaying the need for more invasive procedures and appealing particularly to younger, active individuals. [Published On: 2023-04-25]
Aster Medcity Introduces Robotic Technology for Knee Replacement Surgeries
Aster Medcity introduced a state-of-the-art, fully automated robot designed explicitly for high-precision knee replacement surgeries. Knee replacement surgery, typically advised for severe joint pain unresponsive to standard treatments, involves replacing the damaged joint surfaces to alleviate discomfort and improve mobility. This robotic system promises to refine this procedure by ensuring increased accuracy and potentially better patient recovery rates. [Published On: 2023-01-23]
Strategy Analysis & Recommendation
The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Joint Replacement Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.
Key Company Profiles
The report delves into recent significant developments in the Joint Replacement Market, highlighting leading vendors and their innovative profiles. These include Aditi Corporation, Aesculap, Inc., Arthrex, Inc., B. Braun SE, Corin Group, DJO Global Inc., Exactech, Inc., Globus Medical, Inc., Integra LifeSciences Corporation, Johnson & Johnson Services, Inc., Kyocera Corporation, Medtronic PLC, Meril Life Sciences Pvt. Ltd., MicroPort Scientific Corporation, NuVasive Inc., Orthofix Medical Inc., Smith & Nephew PLC, Stryker Corporation, Uteshiya Medicare Private Limited, Wright Medical Group N.V., and Zimmer Biomet Holdings, Inc..
Market Segmentation & Coverage